Reassuring Market Adoption of Daybue Fuels Acadia's Strategic Advancements, Analysts Boost Price Targets
July 14, 2023 at 14:47 PM EDT
Acadia Pharmaceuticals Inc(NASDAQ: ACAD) expanded its current licensing agreement for trofinetide withNeuren ...